Would treatment decisions about secondary prevention of CVD based on estimated lifetime benefit rather than 10-year risk reduction be cost-effective? by Gijs F. N. Berkelmans, Jacoba P. Greving, Yolanda van der Graaf, Frank L. J. Visseren, Jannick A. N. Dorresteijn

Get full text

Identifying treatment response to antihypertensives in patients with obesity-related hypertension by Ilse M. Schrover, Jannick A. N. Dorresteijn, Jodine E. Smits, A. H. Jan Danser, Frank L. J. Visseren, Wilko Spiering

Get full text

Communicating personalised statin therapy-effects as 10-year CVD-risk or CVD-free life-expectancy: does it improve decisional conflict? Three-armed, blinded, randomised controlled... by Yvo M Smulders, Guy E H M Rutten, Frank L J Visseren, Yolanda van der Graaf, Olga C Damman, Nicole E M Jaspers, Jannick A N Dorresteijn, Corline Brouwers

Get full text

Origins and Previous Applications of Causal-Benefit Models by Jannick A.N. Dorresteijn, MD, PhD, MSc, Steven H.J. Hageman, MD, PhD, MSc, Frank L.J. Visseren, MD, PhD, Deepak L. Bhatt, MD, MPH, MBA

Get full text

Impact of the VTE-PREDICT calculator on clinicians’ decision making in fictional patients with venous thromboembolism: a randomized controlled trial by Daniël Duijzer, Maria A. de Winter, Marc Carrier, Alexander T. Cohen, John-Bjarne Hansen, Karin A.H. Kaasjager, Ajay K. Kakkar, Saskia Middeldorp, Henrik T. Sørensen, Frank L.J. Visseren, Philip S. Wells, Jannick A.N. Dorresteijn, Mathilde Nijkeuter

Get full text

Routinely measured hematological parameters and prediction of recurrent vascular events in patients with clinically manifest vascular disease. by Daniel Kofink, Steven A Muller, Riyaz S Patel, Jannick A N Dorresteijn, Gijs F N Berkelmans, Mark C H de Groot, Wouter W van Solinge, Saskia Haitjema, Tim Leiner, Frank L J Visseren, Imo E Hoefer, Folkert W Asselbergs, SMART Study Group

Get full text

Cohort profile: the Utrecht Cardiovascular Cohort–Second Manifestations of Arterial Disease (UCC-SMART) Study–an ongoing prospective cohort study of patients at high cardiovascular... by Michiel L Bots, N Charlotte Onland-Moret, Pim A de Jong, L Jaap Kappelle, Frank L J Visseren, Folkert W Asselbergs, Ynte M Ruigrok, Steven H J Hageman, Jan Westerink, Maarten van Smeden, Gert J de Borst, Maarten J Cramer, Jannick A N Dorresteijn, Marianne C Verhaar, Mirjam I Geerlings, Maria C Castelijns, Marga A G Helmink, Marielle H Emmelot-Vonk, Niels P van der Kaaij, A Titia Lely, Manon G van der Meer, Barend M Mol, Hendrik M Nathoe, Rutger B van Petersen, Martin Teraa, Angela Vandersteen

Get full text